- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 13, 2026 | 1.46M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 676.17K sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 227.22K sh |
| Capex | Q1 2026 · Mar 31, 2026 | $6.18K |
| Capex | Q1 2026 · Mar 31, 2025 | $0 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$4.65M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$3.24M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $2.95M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $7.2M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $70.71K |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $4.52M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $10.97M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $6.18M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $4.58M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $4.1M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $4.58M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $4.1M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $4.08M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $8.1M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.65M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $8.62M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$7.30 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$18.93 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$7.30 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$18.93 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.43M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.09M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $3.54M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $3.24M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$4.94M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$4.3M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$4.98M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$4.34M |